CLYM — CLIMB BIO INC
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 114 家机构在其最新 13F 申报中持有 CLYM(CLIMB BIO INC),合计申报市值 $751.72M,对应 59.79M 股。按股数计算较上季度增持 56.8%(+16.27M 股),申报市值环比上升 204.7%。持仓集中度较高:前五大持有人占申报市值的 46.5%,前十大的集中度为 64.2%。
与上一季度相比,55 家新建仓位、33 家加仓、19 家减仓、24 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
CLIMB BIO INC(CLYM)的主要机构持有人包括 RA CAPITAL MANAGEMENT, L.P.、Fidelity Management & Research (FMR)、UBS Group AG,按 13F 申报市值在本页 211 家持有人中排名居前。
CLYM 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 80 | 29.90M | $343.01M | +39.5% |
| Q2 2026 | 114 | 59.79M | $751.72M | +56.8% |
| Q1 2026 | 83 | 35.04M | $226.92M | -3.5% |
| Q4 2025 | 65 | 33.04M | $157.04M | -36.6% |
| Q3 2025 | 67 | 45.59M | $90.57M | -10.1% |
| Q2 2025 | 69 | 50.87M | $62.41M | -2.7% |
| Q1 2025 | 78 | 52.43M | $63.26M | +3.0% |
| Q4 2024 | 78 | 56.14M | $99.93M | +0.0% |
表内 8 个季度中,机构持股合计减少 47%(Q4 2024 → Q3 2026);单季变动最大的是 Q2 2026(+56.8%)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 9.27M | $106.32M | 0.01% | 增持 | |
| 4.49M | $51.49M | 0.02% | 增持 | |
| 2.94M | $33.69M | 0.00% | 增持 | |
| 2.38M | $27.25M | 0.00% | 增持 | |
| 1.85M | $21.22M | 0.00% | 增持 | |
| 1.12M | $12.85M | 0.00% | 增持 | |
| 972.00K | $11.15M | 0.52% | 持有 | |
| 951.06K | $10.91M | 0.00% | 增持 | |
| 730.00K | $8.37M | 0.12% | 新进 | |
| 558.52K | $6.41M | 0.01% | 新进 | |
| 501.20K | $5.75M | 0.00% | 增持 | |
| 401.55K | $4.61M | 0.00% | 增持 | |
| 360.65K | $4.14M | 0.40% | 持有 | |
| 303.70K | $3.49M | 0.00% | 增持 | |
| 290.85K | $3.34M | 0.06% | 新进 | |
| 287.30K | $3.30M | 0.00% | 增持 | |
| 254.11K | $2.91M | 0.01% | 增持 | |
| 181.51K | $2.08M | 0.00% | 增持 | |
| 181.46K | $2.08M | 0.00% | 增持 | |
| 157.20K | $1.80M | 0.00% | 增持 | |
| 135.01K | $1.55M | 0.00% | 增持 | |
| 132.90K | $1.52M | 0.33% | 增持 | |
| 130.18K | $1.49M | 0.00% | 增持 | |
| 102.95K | $1.18M | 0.00% | 减持 | |
| 86.55K | $992.76K | 0.00% | 增持 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
Q1 2026 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 11.30M | $77.41M | 0.82% | 持有 | |
| 2.59M | $17.77M | 1.37% | 减持 | |
| 1.92M | $13.13M | 0.00% | 持有 | |
| 1.53M | $10.48M | 0.40% | 新进 | |
| 1.33M | $9.14M | 2.10% | 增持 | |
| 1.28M | $8.74M | 0.00% | 增持 | |
| 1.28M | $8.74M | 0.01% | 增持 | |
| 1.18M | $8.07M | 0.00% | 新进 | |
| 1.00M | $6.87M | 0.44% | 减持 | |
| 773.12K | $5.30M | 0.01% | 增持 | |
| 700.00K | $4.79M | 0.26% | 减持 | |
| 684.91K | $4.69M | 0.58% | 新进 | |
| 600.95K | $4.12M | 0.03% | 持有 | |
| 597.66K | $4.09M | 0.28% | 减持 | |
| 420.52K | $2.88M | 0.32% | 减持 | |
| 419.25K | $2.87M | 0.47% | 减持 | |
| 401.65K | $2.75M | 0.00% | 增持 | |
| 345.66K | $2.37M | 0.00% | 增持 | |
| 313.00K | $2.15M | 0.00% | 增持 | |
| 310.61K | $2.13M | 0.00% | 减持 | |
| 286.13K | $1.96M | 0.69% | 新进 | |
| 250.10K | $1.71M | 0.00% | 增持 | |
| 234.18K | $1.60M | 0.00% | 增持 | |
| 217.77K | $1.49M | 0.07% | 新进 | |
| 217.30K | $1.49M | 0.00% | 减持 |
Q4 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 11.29M | $77.71M | 0.80% | 减持 | |
| 2.67M | $10.69M | 1.22% | 新进 | |
| 1.92M | $7.70M | 0.00% | 增持 | |
| 1.43M | $5.73M | 0.45% | 增持 | |
| 1.34M | $5.36M | 0.00% | 增持 | |
| 1.30M | $5.20M | 0.32% | 持有 | |
| 1.03M | $4.11M | 0.28% | 持有 | |
| 979.53K | $3.92M | 1.27% | 新进 | |
| 932.25K | $3.73M | 0.74% | 增持 | |
| 716.68K | $2.87M | 0.01% | 新进 | |
| 600.95K | $2.40M | 0.02% | 新进 | |
| 566.71K | $2.27M | 0.01% | 增持 | |
| 565.99K | $2.26M | 1.93% | 增持 | |
| 463.65K | $1.85M | 0.15% | 持有 | |
| 445.34K | $1.78M | 0.00% | 增持 | |
| 389.31K | $1.56M | 0.00% | 减持 | |
| 320.60K | $1.28M | 0.00% | 减持 | |
| 310.76K | $1.24M | 0.00% | 持有 | |
| 304.01K | $1.22M | 0.00% | 增持 | |
| 296.31K | $1.19M | 0.00% | 减持 | |
| 296.31K | $1.19M | 0.00% | 减持 | |
| 246.20K | $984.80K | 0.00% | 增持 | |
| 239.04K | $956.17K | 0.00% | 新进 | |
| 224.88K | $899.53K | 0.00% | 增持 | |
| 201.65K | $806.61K | 0.04% | 新进 |
Q3 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 31.42M | $63.15M | 0.78% | 持有 | |
| 1.32M | $2.64M | 0.00% | 减持 | |
| 1.30M | $2.61M | 0.25% | 减持 | |
| 1.03M | $2.07M | 0.15% | 持有 | |
| 1.00M | $2.01M | 0.08% | 持有 | |
| 735.50K | $1.48M | 0.00% | 减持 | |
| 561.87K | $1.13M | 1.01% | 增持 | |
| 547.17K | $1.10M | 0.04% | 减持 | |
| 537.10K | $1.08M | 0.00% | 增持 | |
| 526.92K | $1.06M | 0.00% | 减持 | |
| 509.79K | $1.02M | 0.03% | 减持 | |
| 485.36K | $975.58K | 0.00% | 持有 | |
| 471.70K | $948.12K | 0.00% | 减持 | |
| 471.70K | $948.12K | 0.00% | 减持 | |
| 463.65K | $931.95K | 0.09% | 持有 | |
| 434.84K | $874.02K | 0.20% | 增持 | |
| 405.40K | $814.86K | 0.00% | 增持 | |
| 329.55K | $662.39K | 0.00% | 减持 | |
| 311.72K | $626.87K | 0.00% | 持有 | |
| 229.89K | $462.08K | 0.00% | 增持 | |
| 150.00K | $301.50K | 0.05% | 减持 | |
| 142.45K | $286.32K | 0.00% | 增持 | |
| 136.49K | $274.34K | 0.10% | 减持 | |
| 133.53K | $268.39K | 0.03% | 增持 | |
| 125.42K | $252.10K | 0.00% | 减持 |
Q2 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 31.42M | $38.96M | 0.66% | 持有 | |
| 2.50M | $3.10M | 0.19% | 增持 | |
| 1.61M | $2.00M | 0.00% | 减持 | |
| 1.50M | $1.86M | 0.29% | 持有 | |
| 1.33M | $1.65M | 0.00% | 减持 | |
| 1.04M | $1.29M | 0.04% | 持有 | |
| 1.03M | $1.28M | 0.14% | 减持 | |
| 1.00M | $1.24M | 0.06% | 持有 | |
| 877.97K | $1.09M | 0.00% | 减持 | |
| 702.13K | $870.65K | 0.39% | 增持 | |
| 555.67K | $689.02K | 0.69% | 持有 | |
| 547.97K | $680.00K | 0.00% | 减持 | |
| 495.50K | $614.42K | 0.00% | 减持 | |
| 485.36K | $601.85K | 0.00% | 新进 | |
| 480.08K | $595.30K | 0.00% | 增持 | |
| 480.08K | $595.30K | 0.00% | 增持 | |
| 463.65K | $574.93K | 0.07% | 新进 | |
| 415.00K | $514.60K | 0.11% | 增持 | |
| 382.48K | $474.28K | 0.00% | 持有 | |
| 311.72K | $386.71K | 0.00% | 减持 | |
| 210.12K | $260.55K | 0.00% | 减持 | |
| 209.84K | $260.20K | 0.07% | 减持 | |
| 201.31K | $249.63K | 0.00% | 增持 | |
| 179.59K | $222.69K | 0.00% | 减持 | |
| 148.18K | $183.74K | 0.00% | 新进 |
新建仓(Q2 2026)
- ADAGE CAPITAL PARTNERS GP, L.L.C. 2.51M 股 · $32.68M
- Cormorant Asset Management, LP 2.11M 股 · $27.46M
- FRONTIER CAPITAL MANAGEMENT CO LLC 1.94M 股 · $25.28M
- Woodline Partners LP 1.58M 股 · $20.63M
- Redmile Group, LLC 1.23M 股 · $15.99M
- GEODE CAPITAL MANAGEMENT, LLC 782.20K 股 · $10.20M
- STEMPOINT CAPITAL LP 742.75K 股 · $9.69M
- AMERIPRISE FINANCIAL INC 657.97K 股 · $8.58M
- Parkman Healthcare Partners LLC 563.48K 股 · $7.35M
- Invesco Ltd 373.44K 股 · $4.87M
- Ikarian Capital, LLC 300.00K 股 · $3.91M
- Ally Bridge Group (NY) LLC 249.17K 股 · $3.25M
完全清仓(较上季)
- MPM BioImpact LLC 卖出 2.59M 股 · $17.77M
- Kynam Capital Management, LP 卖出 1.00M 股 · $6.87M
- Marshall Wace 卖出 773.12K 股 · $5.30M
- SILVERARC CAPITAL MANAGEMENT, LLC 卖出 684.91K 股 · $4.69M
- DIADEMA PARTNERS LP 卖出 286.13K 股 · $1.96M
- Longaeva Partners L.P. 卖出 217.77K 股 · $1.49M
- STATE STREET CORP 卖出 132.00K 股 · $904.20K
- Seven Fleet Capital Management LP 卖出 130.65K 股 · $894.98K
- Peapod Lane Capital LLC 卖出 108.88K 股 · $739.80K
- 683 Capital Management, LLC 卖出 90.00K 股 · $616.50K
- Persistent Asset Partners Ltd 卖出 72.33K 股 · $495.43K
- Point72 Asset Management 卖出 59.09K 股 · $404.77K
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fidelity Management & Research (FMR) | 9.27M | 6.79M | 6.40K | 6.35K | 7.14K | 7.63K | 2.65K | 13.56K | 16 | — | — | — | — | — | — | — | — | 9 | 94 | — |
| UBS Group AG | 4.49M | 3.40M | 85.94K | 71.32K | 405.40K | 382.48K | 382.23K | 415.36K | 16.25K | 2.22K | 5.92K | — | 89 | — | — | — | — | 2.28K | 1.62K | 4.44K |
| BlackRock Inc | 2.94M | 2.35M | 401.65K | 389.31K | 735.50K | 877.97K | 2.30M | 2.31M | 1.87M | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.38M | 1.70M | 1.18M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 1.85M | — | 132.00K | 128.90K | 103.10K | 103.10K | 378.54K | 378.54K | 315.04K | 59.01K | 21.70K | 21.70K | 21.70K | — | — | — | — | — | — | — |
| Morgan Stanley | 1.12M | 365.09K | 234.18K | 148.54K | 86.33K | 99.46K | 176.98K | 226.85K | 78.18K | 9.88K | 1.71K | 1.71K | 1.71K | 1.71K | 62.32K | 145 | 4.77K | 6.63K | 5.68K | 10.12K |
| Affinity Asset Advisors, LLC | 972.00K | 972.00K | 700.00K | 1.30M | 1.30M | 1.50M | 1.50M | 500.00K | 1.50M | 1.67M | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 951.06K | 782.20K | 313.00K | 310.76K | 311.72K | 311.72K | 673.81K | 660.83K | 651.30K | 171.60K | 66.63K | 66.63K | 66.63K | 64.01K | 64.01K | 64.01K | 64.14K | 64.14K | 113.02K | 115.67K |
| EVENTIDE ASSET MANAGEMENT, LLC | 730.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Marshall Wace | 558.52K | — | 773.12K | 304.01K | 229.89K | 36.74K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 501.20K | 239.66K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| DIMENSIONAL FUND ADVISORS LP | 401.55K | 239.45K | 104.44K | — | — | — | — | — | 18.28K | 12.56K | — | — | — | — | — | — | — | — | — | — |
| NAN FUNG TRINITY (HK) Ltd | 360.65K | 360.65K | 420.52K | 463.65K | 463.65K | 463.65K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| TD ASSET MANAGEMENT INC | 303.70K | 267.10K | 250.10K | 246.20K | 89.40K | 89.40K | 89.40K | 89.40K | 89.40K | — | — | — | — | — | — | — | — | — | — | — |
| Jefferies Financial Group Inc. | 290.85K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 287.30K | 195.04K | 158.66K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Squarepoint Ops LLC | 254.11K | 25.96K | 42.97K | — | 17.70K | 19.64K | — | 30.84K | — | — | — | — | — | — | — | — | — | — | — | — |
| FIFTH THIRD BANCORP | 181.51K | 164.92K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Manulife Financial | 181.46K | 164.71K | 156.32K | 140.62K | 38.90K | 38.90K | 40.12K | 38.90K | 49.52K | — | — | — | — | — | — | — | — | — | — | — |
| LPL Financial LLC | 157.20K | 51.17K | 60.38K | 62.00K | 61.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold CLYM?
As of 2026-Q2, 114 institutional funds reported holding CLYM (CLIMB BIO INC) in SEC 13F filings, with a combined reported value of $751.72M.
How many shares of CLYM do institutions own?
13F filers reported 59.79M shares of CLYM, worth $751.72M in aggregate at the end of 2026-Q2.
Is institutional ownership of CLYM rising or falling?
Share counts moved +56.8% versus the prior quarter — accumulation.
Who are the top institutional holders of CLYM?
The largest 13F holders are RA CAPITAL MANAGEMENT, L.P., Fidelity Management & Research (FMR), UBS Group AG, BRAIDWELL LP, BlackRock Inc; the top 25 are ranked at the top of this page.
Who are the major shareholders of CLIMB BIO INC?
The major shareholders of CLIMB BIO INC (CLYM) by reported 13F value are RA CAPITAL MANAGEMENT, L.P., Fidelity Management & Research (FMR), UBS Group AG, BRAIDWELL LP, BlackRock Inc, among 211 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.